A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 256 participants.
Also called NCT03560271
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 256 participants
- Sponsor
- NovMetaPharma Co., Ltd.
- Registry
-
NCT03560271
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03560271. Randomized; quadruple masking; primary purpose treatment. Start 2018-06-18 (actual); primary completion 2019-06-25 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- Cyclo-Z
- Intervention (Other)
- Placebo
- Lead sponsor
- NovMetaPharma Co., Ltd.
- Collaborator
- InClin, Inc.
- Collaborator
- FGK Clinical Research GmbH
Record details
- Record id
cardio:ct-nct03560271- Content hash
16693852b552e7425c916d0a73bad0f844c481e632e83f679ac65ce5684575f7